This was researched by a study in 2019 by Carbone et al. They included 41 patients in their study and arrived at the conclusion that at the three-year follow-up, high levels of osteopontin correlated with greater T2DM remission. This evidence concerns the gene SPP1 and type 2 diabetes mellitus.